Cargando…
Tetrandrine inhibits the proliferation of mesangial cells induced by enzymatically deglycosylated human IgA1 via IgA receptor/MAPK/NF-κB signaling pathway
Objective: Despite the use of renin-angiotensin system blockade and immunosuppressive drugs, including corticosteroids, the current treatment regimens for Immunoglobulins A nephropathy (IgAN) are severely limited. The proliferation of mesangial cell and deposition of deglycosylated human IgA1 immune...
Autores principales: | Xu, Wencheng, Song, Wanci, Chen, Shuhe, Jin, Shanshan, Xue, Xue, Min, Jinwen, Wang, Xiaoqin, You, Pengtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308221/ https://www.ncbi.nlm.nih.gov/pubmed/37397485 http://dx.doi.org/10.3389/fphar.2023.1150829 |
Ejemplares similares
-
IgA1 dominant subclass of latent IgA mesangial deposition in donated kidney
por: Oka, Kazumasa, et al.
Publicado: (2016) -
Identification of IgA autoantibodies targeting mesangial cells redefines the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023) -
Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy
por: Wada, Yukihiro, et al.
Publicado: (2018) -
Analysis of O-glycoforms of the IgA1 hinge region by sequential deglycosylation
por: Ohyama, Yukako, et al.
Publicado: (2020) -
Dimeric and polymeric IgA, but not monomeric IgA, enhance the production of IL-6 by human renal mesangial cells
por: Reterink, T. J. F., et al.
Publicado: (1996)